Venetoclax and Eprenetapopt for the Treatment of Relapsed of Refractory Mantle Cell Lymphoma
Clinical trial NCT04990778 · WITHDRAWN
Trial details
- NCT number
- NCT04990778
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-03-24
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.